Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Fabry Registry:
- People who have a confirmed diagnosis of Fabry disease, meaning they have documented low levels of a specific enzyme (alpha-galactosidase) in their blood or white blood cells, and/or a known change (mutation) in the gene related to that enzyme.
- People who have signed the required consent and authorization forms.
Fabry Pregnancy Sub-registry (in addition to the above):
- Women who are already enrolled in the Fabry Registry.
- Women who are currently pregnant, or who have previously been pregnant with appropriate medical records available.
- Women who have signed the required consent and authorization forms before any Sub-Registry data is collected.
Who may not be able to join:
Fabry Registry:
- There are no exclusion criteria listed for the Fabry Registry.
Fabry Pregnancy Sub-registry:
- There are no exclusion criteria listed for the Pregnancy Sub-registry.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Genzyme, a Sanofi Company
Phone: 800-633-1610
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
6 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Fabry Registry: To evaluate the long-term safety and effectiveness of Fabrazyme®; Fabry Pregnancy Sub-registry: pregnancy outcomes, including complications and infant growth
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.